Hong Jian - Shanghai Jiaotong University School of Medicine Affiliated Chest Hospital

基本信息

Career Trajectory

Bio

简红，女，主任医师，医学硕士，长期从事呼吸内科及胸部肿瘤疾病的临床诊断和治疗，尤其是肺癌的诊断和综合治疗，近年来致力于肺癌临床治疗的前沿研究：自体外周血干细胞支持下的高剂量化疗和靶向治疗，在此领域积累治疗小细胞肺癌和非小细胞肺癌的第一手临床资料和相当的经验，并在国内处于领先水平。

简历及培训经历
1987年毕业于上海第二医科大学医学专业
现二医大在职研究生课程进修班在读

Research Interests

Papers共 113 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

SHR-A1811 (antibody-drug conjugate) in advanced HER2-mutant non-small cell lung cancer: a multicenter, open-label, phase 1/2 study

Ziming Li, Zhengbo Song, Wei Hong,Nong Yang, Yongsheng Wang,Hong Jian,Zibin Liang, Sheng Hu,Min Peng, Yan Yu,Yan Wang, Zicong Jiao,

Signal transduction and targeted therapyno. 1 (2024): 182-182

Cited0Views0WOSBibtex

SHR-A1811 (antibody-drug conjugate) in advanced HER2-mutant non-small cell lung cancer: a multicenter, open-label, phase 1/2 study

Ziming Li, Zhengbo Song,Wei Hong,Nong Yang,Yongsheng Wang,Hong Jian,Zibin Liang,Sheng Hu,Min Peng,Yan Yu,Yan Wang, Zicong Jiao,

Signal Transduction and Targeted Therapyno. 1 (2024): 1-10

Cited0Views0Bibtex

Befotertinib (D-0316) versus icotinib as first-line therapy for patients with EGFR-mutated locally advanced or metastatic non-small-cell lung cancer: a multicentre, open-label, randomised phase 3 study

Shun Lu,Jianying Zhou,Hong Jian,Lin Wu,Ying Cheng,Yun Fan,Jian Fang,Gongyan Chen,Zhihong Zhang,Dongqing Lv,Liyan Jiang,Rong Wu,

The Lancet. Respiratory medicine（2023）

Cited3Views0WOSBibtex

Discovery of Novel, Selective Prostaglandin EP4 Receptor Antagonists with Efficacy in Cancer Models

Debasis Das,Dandan Qiao, Zhonghe Liu,Lingzhi Xie, Yong Li,Jingbing Wang, Jianhe Jia, Yuxi Cao,Jian Hong

ACS medicinal chemistry lettersno. 6 (2023): 727-736

Cited0Views0WOSBibtex

Sintilimab plus chemotherapy for patients with EGFR- mutated non-squamous non-small-cell lung cancer with disease progression after EGFRtyrosine-kinase inhibitor therapy (ORIENT-31): second interim analysis from a double- blind, randomised, placebo-controlled, phase 3 trial

Shun Lu,Lin Wu,Hong Jian,Ying Cheng, Qiming Wang, Jian Fang,Ziping Wang, Yanping Hu,Liang Han,Meili Sun,Liyun Miao, Cuimin Ding,

LANCET RESPIRATORY MEDICINEno. 7 (2023): 624-636

Cited0Views0Bibtex

Sintilimab plus chemotherapy for patients with EGFR-mutated non-squamous non-small-cell lung cancer with disease progression after EGFR tyrosine-kinase inhibitor therapy (ORIENT-31): second interim analysis from a double-blind, randomised, placebo-controlled, phase 3 trial

Shun Lu,Lin Wu,Hong Jian,Ying Cheng,Qiming Wang,Jian Fang,Ziping Wang,Yanping Hu,Liang Han,Meili Sun,Liyun Miao,Cuimin Ding,

The Lancet. Respiratory medicine（2023）

Cited7Views0WOSBibtex

D-1553 (Garsorasib), a Potent and Selective Inhibitor of KRASG12C in Patients With NSCLC: Phase 1 Study Results

Ziming Li,Zhengbo Song,Yanqiu Zhao,Pingli Wang,Liyan Jiang,Yi Gong,Jianying Zhou,Hong Jian,Xiaorong Dong,Wu Zhuang,Shundong Cang,Nong Yang,

J Thorac Oncol（2023）

Cited5Views0WOSBibtex

Abstract CT204: Safety, tolerability, pharmacokinetics, and efficacy of SHR-A1811, an antibody-drug conjugate, in patients with advanced HER2-mutant non-small cell lung cancer (NSCLC): a multicenter, open-label, phase 1/2 study

Shun Lu,Hong Jian,Wei Hong,Zhengbo Song,Nong Yang,Sheng Hu, Zhongxing Liang,Yongsheng Wang,Yan Wang,Min Peng,Yan Yu, You Li,

Cancer Researchno. 8_Supplement (2023): CT204-CT204

Cited0Views0Bibtex

An open, observational, three-arm clinical study of 2-3 cycles of treatment as neoadjuvant therapy in operable locally advanced non-small cell lung cancer: An interim analysis

Linping Gu,Xue Wang,Yile Sun,Yunhua Xu,Xiaomin Niu,Ruiying Zhao,Yaxian Yao,Hong Jian,Yuchen Han,Jinwang Wei,Zhiwei Chen,Shun Lu

FRONTIERS IN IMMUNOLOGY（2022）

Cited2Views0WOSBibtex

Targeting FAPα-expressing hepatic stellate cells overcomes resistance to anti-angiogenics in colorectal cancer liver metastasis models

Ming Qi,Shuran Fan,Maohua Huang,Jinghua Pan, Yong Li,Qun Miao,Wenyu Lyu, Xiaobo Li,Lijuan Deng,Shenghui Qiu,Tongzheng Liu,Weiqing Deng,

The Journal of clinical investigationno. 3 (2022)

Cited28Views0WOSBibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn

Hong Jian(简红)

Chief physician

Papers共 113 篇Author StatisticsCo-AuthorSimilar Experts